Skip to main content
. 2017 Jul 20;7:6019. doi: 10.1038/s41598-017-06131-0

Table 1.

Details of predicted in silico ADMET risk range and risk parameters of compound P-902 and standard anticancer drug topotecan.

Risk Absorption P450 oxidation Mutagenicity Toxicity ADMET Risk Risk Parameters
Range 0–8 0–6 0–4 0–7 0–24
P-902 3.26 0.0 0.0 0.96 4.22 Size, charge, water solubility, lipophilicity
Topotecan (control) 0.0 0.0 2.0 2.0 2.0 Hepatotoxicity, inhibition of 3A4 oxidation of midazolam